SCHEMBL20056528

SCHEMBL20056528

COc1cc(OC)cc(-c2ccc(O)c(C)c2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 5/20 0.60
ABCB1 P08183 5/20 0.60
BCR P11274 5/20 0.60
CYP3A4 P08684 2/20 0.53
CYP1A1 P04798 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2E1 P05181 1/20 0.53
CYP2C8 P10632 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2A6 P11509 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP4B1 P13584 1/20 0.53
CYP2B6 P20813 1/20 0.53
CYP3A5 P20815 1/20 0.53
CYP2A7 P20853 1/20 0.53
CYP3A7 P24462 1/20 0.53
CYP2F1 P24903 1/20 0.53
CYP2C18 P33260 1/20 0.53
CYP2C19 P33261 1/20 0.53
CYP2J2 P51589 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20056622 0.88 ESR2 (0.58) ABL1ABCB1BCRCYP3A4CYP1A1
SCHEMBL675046 0.81 HSD17B1 (0.63) CYP3A4CYP2D6CYP2C19HSD17B1HSD17B2
SCHEMBL31574448 0.81 HSD17B1 (0.63) CYP3A4CYP2D6CYP2C19HSD17B1HSD17B2
SCHEMBL29696046 0.81 HSD17B1 (0.68) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL26979937 0.81 HSD17B1 (0.68) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL272034 0.81 HSD17B1 (0.68) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL29429121 0.81 HSD17B1 (0.68) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
Hydrogen Sulfide SCHEMBL6269773 0.79 HSD17B1 (0.65) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
Hydrogen Sulfide SCHEMBL22042810 0.79 HSD17B1 (0.65) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3811825 0.79 HSD17B1 (0.72) CYP3A4CYP2D6CYP2C19HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970353-B1 MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS VERTEX PHARMA (US) 2018-04-18 EP disclosed